1. Home
  2. COCP vs SINT Comparison

COCP vs SINT Comparison

Compare COCP & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.05

Market Cap

15.3M

Sector

Health Care

ML Signal

N/A

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

N/A

Current Price

$3.49

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
SINT
Founded
2006
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3M
14.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
COCP
SINT
Price
$1.05
$3.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$16.00
AVG Volume (30 Days)
103.2K
37.0K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$80.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$1.71
52 Week High
$2.67
$7.36

Technical Indicators

Market Signals
Indicator
COCP
SINT
Relative Strength Index (RSI) 48.85 41.57
Support Level $1.03 $3.46
Resistance Level $1.19 $3.94
Average True Range (ATR) 0.06 0.17
MACD -0.01 -0.04
Stochastic Oscillator 22.73 1.47

Price Performance

Historical Comparison
COCP
SINT

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: